| Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-driven Src-Akt bypass signaling YJ Kim, K Jung, DS Baek, SS Hong, YS Kim Oncogene 36 (18), 2543-2552, 2017 | 53 | 2017 |
| Production of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification WY Seo, JH Kim, DS Baek, SJ Kim, S Kang, WS Yang, JA Song, MS Lee, ... Scientific reports 7 (1), 15946, 2017 | 44 | 2017 |
| Construction of a large synthetic human Fab antibody library on yeast cell surface by optimized yeast mating DS Baek, YS Kim Journal of microbiology and biotechnology 24 (3), 408-420, 2014 | 29 | 2014 |
| Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer YJ Kim, DS Baek, S Lee, D Park, HN Kang, BC Cho, YS Kim Cancer letters 466, 23-34, 2019 | 28 | 2019 |
| Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif DS Baek, YS Kim Biochemical and biophysical research communications 463 (3), 414-420, 2015 | 24 | 2015 |
| FGFR4-targeted Chimeric antigen receptors combined with anti-myeloid polypharmacy effectively treat orthotopic Rhabdomyosarcoma PM Sullivan, R Kumar, W Li, V Hoglund, L Wang, Y Zhang, M Shi, D Beak, ... Molecular cancer therapeutics 21 (10), 1608-1621, 2022 | 14 | 2022 |
| A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivo DS Baek, YJ Kim, S Vergara, A Conard, C Adams, G Calero, R Ishima, ... Cancer letters 525, 97-107, 2022 | 14 | 2022 |
| Immunoglobulin Fc-fused peptide without C-terminal Arg or Lys residue augments neuropilin-1-dependent tumor vascular permeability DS Baek, JH Kim, YJ Kim, YS Kim Molecular pharmaceutics 15 (2), 394-402, 2018 | 9 | 2018 |
| Human antibodies targeting ENPP1 as candidate therapeutics for cancers X Chu, DS Baek, W Li, T Shyp, B Mooney, MG Hines, GB Morin, ... Frontiers in Immunology 14, 1070492, 2023 | 8 | 2023 |
| Human antibody domains and fragments targeting neutrophil elastase as candidate therapeutics for cancer and inflammation-related diseases X Chu, Z Sun, DS Baek, W Li, JW Mellors, SD Shapiro, DS Dimitrov International Journal of Molecular Sciences 22 (20), 11136, 2021 | 8 | 2021 |
| Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates YJ Kim, W Li, DV Zhelev, JW Mellors, DS Dimitrov, DS Baek Frontiers in Oncology 13, 1124039, 2023 | 6 | 2023 |
| Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells N Saha, DS Baek, RP Mendoza, D Robev, Y Xu, Y Goldgur, ... Biomedicine & Pharmacotherapy 161, 114494, 2023 | 3 | 2023 |
| Yeast Mating as a Tool for Highly Effective Discovery and Engineering of Antibodies via Display Methodologies DS Baek, SW Park, C Adams, DS Dimitrov, YS Kim Yeast Surface Display, 313-333, 2022 | 1 | 2022 |
| Molecules that bind to neutrophil elastase polypeptides DB Dimiter Stanchev Dimitrov, Xiaojie CHU, Steven David SHAPIRO, John W ... WO Patent WO2023133338A2, 2023 | | 2023 |
| Discovery and pre-clinical evaluation of antibodies to the NKG2A inhibitory receptor DS Baek, YJ Kim, W Li, BJC Macatangay, JC Cyktor, MG Hines, ... bioRxiv, 2022.05. 18.492494, 2022 | | 2022 |
| MOLECULES THAT BIND TO CD66e POLYPEPTIDES DB Dimiter Stanchev Dimitrov, John W. Mellors WO Patent WO2022192281A1, 2022 | | 2022 |
| Molecules that bind to cd94/nkg2a heterodimer polypeptides JWM Dimiter Stanchev Dimitrov, Dusan Baek, Yae Jin KIM WO Patent WO2023114176A2, 2022 | | 2022 |
| Binders and chimeric antigen receptors which specifically bind fibroblast growth factor receptor 4 DSB Rimas J. ORENTAS, Dimiter Stanchev Dimitrov, Wei Li WO Patent WO2022076898A1, 2021 | | 2021 |
